• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[转移性肾细胞癌是否有手术治疗指征?如果有,其科学依据是什么?]

[Is surgical treatment ever indicated in metastatic renal cell carcinoma and if so, based on which scientific rationale?].

作者信息

Burger M

机构信息

Klinik für Urologie Lehrstuhl der Universität Regensburg, Caritas-Krankenhaus St. Josef, Landshuter Str. 65, 93053, Regensburg, Deutschland.

出版信息

Urologe A. 2017 May;56(5):617-623. doi: 10.1007/s00120-017-0357-9.

DOI:10.1007/s00120-017-0357-9
PMID:28314970
Abstract

BACKGROUND

Metastasis is a common event in renal cell carcinoma. Surgical resection of metastases may be feasible in two scenarios: aiming at palliation, which may be feasible due to reduced radiosensitivity of renal cell cancer, and aiming at prolonging survival, which may be feasible given the rather good prognosis of some patterns of metastasis.

OBJECTIVE

This review intends to reflect on current evidence for surgical resection of metastases in both scenarios. The literature was searched in PubMed and respective guidelines were reviewed.

RESULTS AND CONCLUSIONS

Palliative resection is mainly feasible to control symptoms like spinal compression; adjuvant radiation is advisable. Resection is markedly feasible, however, for improvement of cancer-specific survival in probably all resectable patterns of metastasis-solitary, multiple, syn- and metachronous, and in all organs-provided complete resection can be achieved. A fairly good prognosis is seen in solitary pulmonary metastasis without concomitant hilar or mediastinal lymph node metastasis and a metachronous appearance following long recurrence-free survival after tumor nephrectomy; complete resection may be considered curative in certain cases. Neo- or adjuvant medical therapy or radiation is not established. In cases lacking complete resectability, stereotactic radiation may be considered as an alternative.

摘要

背景

转移是肾细胞癌的常见事件。转移灶的手术切除在两种情况下可能可行:一是旨在缓解症状,鉴于肾细胞癌对放疗的敏感性降低,这可能可行;二是旨在延长生存期,鉴于某些转移模式预后相对较好,这也可能可行。

目的

本综述旨在思考上述两种情况下转移灶手术切除的现有证据。检索了PubMed中的文献并查阅了相关指南。

结果与结论

姑息性切除主要可行于控制如脊髓压迫等症状;辅助放疗是可取的。然而,对于可能所有可切除的转移模式——孤立性、多发性、同时性和异时性,以及在所有器官中——只要能实现完全切除,切除对于改善癌症特异性生存明显可行。在无肺门或纵隔淋巴结转移的孤立性肺转移以及肾肿瘤切除术后长期无复发生存后的异时性转移中,预后相当良好;在某些情况下,完全切除可被视为治愈性的。新辅助或辅助药物治疗或放疗尚未确立。在缺乏完全可切除性的情况下,立体定向放疗可被视为一种替代方法。

相似文献

1
[Is surgical treatment ever indicated in metastatic renal cell carcinoma and if so, based on which scientific rationale?].[转移性肾细胞癌是否有手术治疗指征?如果有,其科学依据是什么?]
Urologe A. 2017 May;56(5):617-623. doi: 10.1007/s00120-017-0357-9.
2
[When is cytoreductive nephrectomy not beneficial for patients with metastatic renal cell carcinoma?].[何时减瘤性肾切除术对转移性肾细胞癌患者无益处?]
Urologe A. 2017 May;56(5):610-616. doi: 10.1007/s00120-017-0363-y.
3
[Should cytoreductive nephrectomy be performed in patients with metastatic renal cell carcinoma and what is the scientific rationale?].[转移性肾细胞癌患者是否应进行减瘤性肾切除术,其科学依据是什么?]
Urologe A. 2017 May;56(5):604-609. doi: 10.1007/s00120-017-0364-x.
4
[Surgical treatment of metastatic penile cancer - what is the scientific rationale?].[转移性阴茎癌的外科治疗——科学依据是什么?]
Urologe A. 2017 May;56(5):624-626. doi: 10.1007/s00120-017-0358-8.
5
Surgical resection does not improve survival in patients with renal metastases to the pancreas in the era of tyrosine kinase inhibitors.在酪氨酸激酶抑制剂时代,手术切除并不能提高胰腺肾转移患者的生存率。
Ann Surg Oncol. 2015;22(6):2094-100. doi: 10.1245/s10434-014-4256-7. Epub 2014 Dec 4.
6
Prognostic factors and survival after pulmonary resection of metastatic renal cell carcinoma.转移性肾细胞癌肺切除术后的预后因素与生存情况
Eur Urol. 2005 Jul;48(1):77-81; discussion 81-2. doi: 10.1016/j.eururo.2005.03.004. Epub 2005 Mar 20.
7
Surgical resection of isolated retroperitoneal lymph node recurrence of renal cell carcinoma following nephrectomy.肾切除术后孤立性腹膜后淋巴结复发的肾细胞癌的手术切除
J Urol. 2008 Jul;180(1):99-103; discussion 103. doi: 10.1016/j.juro.2008.03.025. Epub 2008 May 15.
8
[When is surgical resection of metastases in testicular germ cell tumors indicated and is there a scientific basis?].[睾丸生殖细胞肿瘤转移灶的手术切除何时适用,是否有科学依据?]
Urologe A. 2017 May;56(5):627-636. doi: 10.1007/s00120-017-0385-5.
9
[Value of metastases surgery in metastatic renal cell carcinoma].
Urologe A. 2002 May;41(3):225-30. doi: 10.1007/s00120-002-0204-4.
10
Surgical treatment of atypical metastasis from renal cell carcinoma (RCC).肾细胞癌(RCC)非典型转移的外科治疗。
BJU Int. 2012 Dec;110(11 Pt B):E559-63. doi: 10.1111/j.1464-410X.2012.11271.x. Epub 2012 May 28.

本文引用的文献

1
Impact of metastasectomy on prognosis in patients treated with targeted therapy for metastatic renal cell carcinoma.转移灶切除术对接受靶向治疗的转移性肾细胞癌患者预后的影响。
J Cancer Res Clin Oncol. 2016 Nov;142(11):2331-8. doi: 10.1007/s00432-016-2217-1. Epub 2016 Aug 23.
2
Impact of resection and systemic therapy on the survival of patients with brain metastasis of metastatic renal cell carcinoma.肾细胞癌脑转移患者手术切除及全身治疗对生存的影响。
J Neurooncol. 2016 Oct;130(1):221-228. doi: 10.1007/s11060-016-2238-2. Epub 2016 Aug 18.
3
Concordance of Pathologic Features Between Metastatic Sites and the Primary Tumor in Surgically Resected Metastatic Renal Cell Carcinoma.
手术切除的转移性肾细胞癌转移部位与原发肿瘤病理特征的一致性
Urology. 2016 Oct;96:106-113. doi: 10.1016/j.urology.2016.06.061. Epub 2016 Jul 21.
4
Complete metastasectomy for renal cell carcinoma: Comparison of five solid organ sites.肾细胞癌的完全性转移灶切除术:五个实体器官部位的比较
J Surg Oncol. 2016 Sep;114(3):375-9. doi: 10.1002/jso.24327. Epub 2016 Jun 23.
5
Metastasectomy, intralesional resection, or stabilization only in the treatment of bone metastases from renal cell carcinoma.肾细胞癌骨转移的治疗中采用转移灶切除术、病损内切除术或仅行固定术。
J Surg Oncol. 2016 Aug;114(2):237-45. doi: 10.1002/jso.24284. Epub 2016 May 9.
6
The Role of Metastasectomy in Patients with Renal Cell Carcinoma with Sarcomatoid Dedifferentiation: A Matched Controlled Analysis.肉瘤样去分化的肾细胞癌患者行转移灶切除术的作用:一项匹配对照分析。
J Urol. 2016 Sep;196(3):678-84. doi: 10.1016/j.juro.2016.03.144. Epub 2016 Mar 29.
7
Spinal metastasectomy of renal cell carcinoma: A 16-year single center experience with a minimum 3-year follow-up.肾细胞癌脊柱转移瘤切除术:一项单中心16年经验,至少随访3年。
J Surg Oncol. 2016 Apr;113(5):587-92. doi: 10.1002/jso.24186. Epub 2016 Feb 5.
8
Pancreatic metastasis from clear cell renal cell carcinoma: outcome of an aggressive approach.透明细胞肾细胞癌的胰腺转移:积极治疗方法的结果
Urology. 2015 Jan;85(1):135-40. doi: 10.1016/j.urology.2014.09.034.
9
Surgical resection does not improve survival in patients with renal metastases to the pancreas in the era of tyrosine kinase inhibitors.在酪氨酸激酶抑制剂时代,手术切除并不能提高胰腺肾转移患者的生存率。
Ann Surg Oncol. 2015;22(6):2094-100. doi: 10.1245/s10434-014-4256-7. Epub 2014 Dec 4.
10
Cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium.细胞减灭性肾切除术治疗肾细胞癌同步转移患者:来自国际转移性肾细胞癌数据库联盟的结果。
Eur Urol. 2014 Oct;66(4):704-10. doi: 10.1016/j.eururo.2014.05.034. Epub 2014 Jun 13.